Microbiomic laboratory solutions company Cmbio announced on Friday that it has acquired the e[datascientist] software platform from CBW Recovery LLP and Eagle Genomics Limited (In Administration) through an Asset Sale Agreement.

Eagle Genomics, established in 2008 and headquartered in Cambridge, UK, is known for its enterprise cloud platform supporting data-intensive life sciences research. The platform excels in curating, integrating, sharing, analyzing and valuing complex scientific data.

This acquisition includes all intellectual property related to Eagle Genomics' business. The transaction supports Cmbio's strategic goals of advancing multi-omics science and expanding its bioinformatics and AI/ML capabilities. It strengthens Cmbio's offering of scalable, validated software solutions for both industry and academia.